BRIEF published on 09/11/2024 at 08:35, 1 year 2 months ago BiVictriX Therapeutics plc Shares Now Trading on JP Jenkins JP Jenkins Share Trading Cancer Therapeutics BiVictriX Bi-Cygni ADCs
BRIEF published on 09/11/2024 at 08:35, 1 year 2 months ago Les actions de BiVictriX Therapeutics plc sont désormais négociées sur JP Jenkins Négociation D'actions J.P. Jenkins BiVictriX Thérapies Contre Le Cancer ADC Bi-Cygni
PRESS RELEASE published on 09/11/2024 at 08:30, 1 year 2 months ago BiVictriX Therapeutics plc Shares now trading on JP Jenkins BiVictriX Therapeutics plc shares are now trading on JP Jenkins, providing a platform for shareholders to buy and sell equity. BiVictriX focuses on developing innovative cancer therapeutics JP Jenkins Shares Trading Shareholder Engagement Cancer Therapeutics BiVictriX Therapeutics Plc
Published on 12/05/2025 at 02:35, 4 hours 46 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 21 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 16 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 21 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 21 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 3 hours 51 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 30 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 56 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 6 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 6 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 21 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 21 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 36 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 36 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
